The function of alternative splicing in the proteome: rewiring protein interactomes to put old functions into new contexts

P Kjer-Hansen, RJ Weatheritt - Nature Structural & Molecular Biology, 2023 - nature.com
Alternative splicing affects more than 95% of multi-exon genes in the human genome. These
changes affect the proteome in a myriad of ways. Here, we review our understanding of the …

LSD1: biologic roles and therapeutic targeting

A Maiques-Diaz, TCP Somervaille - Epigenomics, 2016 - Taylor & Francis
LSD1 (KDM1A; BHC110; AOF2) was the first protein reported to exhibit histone demethylase
activity and has since been shown to have multiple essential roles in mammalian biology …

Precise temporal regulation of alternative splicing during neural development

SM Weyn-Vanhentenryck, H Feng… - Nature …, 2018 - nature.com
Alternative splicing (AS) is one crucial step of gene expression that must be tightly regulated
during neurodevelopment. However, the precise timing of developmental splicing switches …

A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation

B Laurent, L Ruitu, J Murn, K Hempel, R Ferrao… - Molecular cell, 2015 - cell.com
Summary Lysine-specific demethylase 1 (LSD1) has been reported to repress and activate
transcription by mediating histone H3K4me1/2 and H3K9me1/2 demethylation, respectively …

Epigenetic etiology of intellectual disability

S Iwase, NG Bérubé, Z Zhou, NN Kasri… - Journal of …, 2017 - Soc Neuroscience
Intellectual disability (ID) is a prevailing neurodevelopmental condition associated with
impaired cognitive and adaptive behaviors. Many chromatin-modifying enzymes and other …

Autism-misregulated eIF4G microexons control synaptic translation and higher order cognitive functions

T Gonatopoulos-Pournatzis, R Niibori, EW Salter… - Molecular cell, 2020 - cell.com
Microexons represent the most highly conserved class of alternative splicing, yet their
functions are poorly understood. Here, we focus on closely related neuronal microexons …

LSD1/KDM1A, a gate-keeper of cancer stemness and a promising therapeutic target

P Karakaidos, J Verigos, A Magklara - Cancers, 2019 - mdpi.com
A new exciting area in cancer research is the study of cancer stem cells (CSCs) and the
translational implications for putative epigenetic therapies targeted against them …

Targeting histone deacetylases in diseases: where are we?

R Benedetti, M Conte, L Altucci - Antioxidants & redox signaling, 2015 - liebertpub.com
Significance: Epigenetic inactivation of pivotal genes involved in cell growth is a hallmark of
human pathologies, in particular cancer. Histone acetylation balance obtained through …

Therapeutic potential of targeting LSD1/KDM1A in cancers

X Zhang, X Wang, T Wu, W Yin, J Yan, Y Sun… - Pharmacological …, 2022 - Elsevier
LSD1 was the first histone demethylase identified by Professor Shi Yang and his team
members in 2004. LSD1 employs FAD as its cofactor, which catalyzes the demethylation of …

LSD1: expanding functions in stem cells and differentiation

C Martinez-Gamero, S Malla, F Aguilo - Cells, 2021 - mdpi.com
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSC) provide a powerful
model system to uncover fundamental mechanisms that control cellular identity during …